Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1998
11/17/1998US5837861 Respiratory system disorders, bronchitis and cystic fibrosis
11/17/1998US5837856 Chirally enriched synthetic phosphonate oligomers
11/17/1998US5837853 Preventive or therapeutic agents for alzheimers disease a screening method of alzheimers disease and tau-protein kinase I originated from human being
11/17/1998US5837738 Administering an aminoguanidine to mammal afflicted with acute or chronic inflammatory disease
11/17/1998US5837737 Hydrazinedicarboximidamide compounds and pharmaceutical composition comprising same
11/17/1998US5837736 Oxygen-free administration to tumors
11/17/1998US5837735 Nimesulide as antiinflammatory agents
11/17/1998US5837734 Method for the treatment of coccidioidomycosis in warm-blooded animals
11/17/1998US5837733 Method for reducing secetion of apolipoprotein B in animals by administering conjugated linoleic acid
11/17/1998US5837731 Fatty acid treatment
11/17/1998US5837730 Reducing the side-effect of glycine for treating nervous system disorder, psychological disorder
11/17/1998US5837729 Viricides and antigrowth agents for htlv virus
11/17/1998US5837728 9-cis retinoic acid esters and amides and uses thereof
11/17/1998US5837727 Method for altering blood lipid levels
11/17/1998US5837725 Controlling cell differentiation
11/17/1998US5837724 Administering darifenacin or salt with acetylcholinesterase inhibitor; alzheimer's disease
11/17/1998US5837723 Pharmaceutical composition useful for treating ophthalmological diseases
11/17/1998US5837720 N-2-(pyrrolidinyl-1)-1-phenethyl) acetamides as kappa receptor antagonists
11/17/1998US5837717 Hydroxamic acid anesthetic compounds
11/17/1998US5837716 Analgesics
11/17/1998US5837714 Poorly soluble drug substance selected from sr48692 and naproxyn dissolved in xylitol and transcutol
11/17/1998US5837713 Treatment of eosinophil-associated pathologies by administration of topical anesthetics and glucocorticoids
11/17/1998US5837712 Annelated dihydropyridines and the use thereof for preparing pharmaceutical preparations
11/17/1998US5837710 Enzyme inhibitors for treatment of aids
11/17/1998US5837709 Use of castanospermine as an anti-inflammatory and immunosupressant agent
11/17/1998US5837707 Dimeric piperidine, tetrahydropyridine and piperazine derivatives
11/17/1998US5837706 Drug for neuroprotection
11/17/1998US5837705 An antagonist of excitatory amino acid and glycine receptor for treating neurodegenerative disorder, stroke, hypoglycemia, ischemic attack, anoxia or epilepsy
11/17/1998US5837703 Amino-alcohol substituted cyclic compounds
11/17/1998US5837702 4-arylamino-benzopyran and related compounds
11/17/1998US5837701 Diseases due to chromosomal abnormalities; administering halperidol, imipraine, trifluoperazien, aminobutyric acid, phenylalanine, vitamin e or ascorbic acid as antioxidant, folic acid, nicotinamide, lithium carbonate, carrier
11/17/1998US5837700 Therapeutic methods and delivery systems utilizing sex steroid precursors
11/17/1998US5837699 High speed asthma and allergic rhinitis treatment; side effect reduction
11/17/1998US5837698 Derivatives of beta-methasone, dexamethasone, budesonide and triamcinolole with nitrate
11/17/1998US5837697 Containing salicylic acid, sunscreen agent and a carrier
11/17/1998US5837696 Method of inhibiting cancer growth
11/17/1998US5837695 Fluorescent chlamydia antigen substrate
11/17/1998US5837694 Method for enhancing neurone survival and agents useful for same
11/17/1998US5837690 Derivatives of triterpenoid acids and uses thereof.
11/17/1998US5837680 Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis
11/17/1998US5837677 Method for the treatment of cancer with Exochelins of Mycobacterium tuberculosis
11/17/1998US5837674 Administering orally or by injection; oligopeptides
11/17/1998US5837673 Camptothecin derivatives
11/17/1998US5837645 Using 3,3-bis(4-hydroxyphenyl)-1-(3h)-isobenzofuranone ensuring that sunscreen is applied evenly and completely
11/17/1998US5837548 Treatment of inflammation by inhibition of lipid body formation
11/17/1998US5837531 Recombinant adenoviruses for gene therapy in cancers
11/17/1998US5837510 Methods and polynucleotide constructs for treating host cells for infection or hyperproliferative disorders
11/17/1998US5837508 Hce3p83 polypeptides and polynucleotides used in the design of protocols for treatment of alzheimer's disease, stroke, cancer, inflammation, arthritis, musculoskeletal disease, heart disease, kidney disease and diagnostic assays for such
11/17/1998US5837451 Identifying composition which affect kinase activity
11/17/1998US5837449 Hybridizable oligonucleotides; genetic engineering; diagnosis, detection and treatment of brain disorders such as alzheimer*s disease
11/17/1998US5837287 Process for preparing solid pharmaceutical dosage forms
11/17/1998US5837286 Taste masking for unplatable formulations
11/17/1998US5837284 Oral dosage form of dl-threo methylphenidate hydrochloride; daily dosage; includes ammonio methacrylate polymer
11/17/1998US5837283 Cationic lipid compositions targeting angiogenic endothelial cells
11/17/1998US5837282 Ionophore-mediated liposome loading
11/17/1998US5837280 Transdermal administration of azapirones
11/17/1998US5837279 Encapsulation of ionizable agents in liposomes
11/17/1998US5837274 Polyurethanes for bactericides and phenols for cleaning compounds
11/17/1998US5837270 Containing 3-chloro-3,5-dimethylphenol and zinc oxide
11/17/1998US5837269 Vaccine compositions and method for enhancing an immune response
11/17/1998US5837266 Composition, barrier film, and method for preventing contact dermatitis
11/17/1998US5837256 Using secoisolariciresinol
11/17/1998US5837255 Method of reducing blood glucose by administering Harunganin or Vismin
11/17/1998US5837251 Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
11/17/1998US5837244 Treating a cell proliferative disorder
11/17/1998US5837233 Method for treating tumors
11/17/1998US5837228 Drug delivery device for controlled release of drugs
11/17/1998US5837224 Method of inhibiting photoaging of skin
11/17/1998US5837008 Intravascular stent and method
11/17/1998US5836948 Spine distraction implant and method
11/17/1998CA2142673C Aluminum/iron chelating compositions
11/17/1998CA2101356C Improvements in or relating to benzothiophenes
11/15/1998CA2237480A1 Heparin-analogous homo- or copolymers, their preparation and their use
11/15/1998CA2237450A1 Preparation having increased in vivo tolerability
11/13/1998CA2237382A1 Substituted 6- and 7-amino-tetrahydroisoquinolinecarboxylic acids
11/13/1998CA2230971A1 G-protein coupled receptor (hofnh30)
11/12/1998WO1998050572A1 HMG-CoA REDUCTASE INHIBITOR PREPARATION PROCESS
11/12/1998WO1998050542A1 Uncoupling protein homologue: ucp 3
11/12/1998WO1998050540A1 MODIFIED ANTISENSE NUCLEOTIDES COMPLEMENTARY TO A SECTION OF THE HUMAN Ha-Ras GENE
11/12/1998WO1998050534A1 Protease inhibitors
11/12/1998WO1998050533A1 Protease inhibitors
11/12/1998WO1998050530A2 Enzymatic nucleic acids: synthesis, selection and use
11/12/1998WO1998050434A1 Methods for eosinophil depletion and compositions therefor
11/12/1998WO1998050432A1 Recombinant antibody-enzyme fusion proteins
11/12/1998WO1998050424A2 Human serine protease precursor
11/12/1998WO1998050419A2 4-aza-steroids as inhibitors of testosterone-5-alpha-reductase
11/12/1998WO1998050415A1 Pregnane 3,2o diol mono- and di-sulphates
11/12/1998WO1998050414A1 B-ring estratriene diol sulphates
11/12/1998WO1998050413A1 Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens
11/12/1998WO1998050412A1 Estrogenic 19-noradnrost-17-one derivatives with an aromatic b-ring
11/12/1998WO1998050411A1 Pharmaceutically acceptable salts of 5alpha-pregnan-3beta, 16alp ha-diol-20-one 3-sulfate useful as progestins and cns disorders
11/12/1998WO1998050410A1 Salts of 5.alpha.-pregn-16-en-3.beta.-ol-20-one 3-sulphate ester with progestin activity
11/12/1998WO1998050399A1 Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
11/12/1998WO1998050397A2 Chimeric oligonucleotides and the use thereof
11/12/1998WO1998050394A1 Nitric oxide carriers based on polyazamacrocycle complexes
11/12/1998WO1998050387A1 Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents
11/12/1998WO1998050386A1 A new class of benzoporphyrin derivative photoactive compounds
11/12/1998WO1998050385A1 SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PHTHALAZINE DERIVATIVES AS GABA ALPHA 5 LIGANDS
11/12/1998WO1998050384A1 Tricyclic pyridone analogues as gaba-a receptor ligands
11/12/1998WO1998050383A1 5-phenyl-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4 ligands
1 ... 6580 6581 6582 6583 6584 6585 6586 6587 6588 6589 6590 6591 6592 6593 6594 6595 6596 6597 6598 6599 6600 ... 7860